Six-week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self-controlled clinical study-Reference-Cited by-同舟云学术

Six-week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self-controlled clinical study

Published:2018-10-01 Issue:2 Volume:45 Page:376-381
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Cai Mei-Hong¹²,Liang Xiao-Yan¹,Wu Yao-Qiu¹,Huang Rui¹,Yang Xing¹

Affiliation:

1. Reproductive Medicine Centre; The Sixth Affiliated Hospital, Sun Yat-Sen University; Guangzhou China

2. Department of Reproductive Medicine Centre, Guangzhou First People's Hospital, School of Medicine; South China University of Technology; Guangzhou China

Funder

National Natural Science Foundation of China

Guangdong Natural Science Foundation

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13823/fullpdf

Reference20 articles.

1. What women want? A scoping survey on women's knowledge, attitudes and behaviours towards ovarian reserve testing and egg freezing;O'Brien;Eur J Obstet Gynecol Reprod Biol,2017

2. Poor responders in in vitro fertilization (IVF) therapy: The challenge continues;Oehninger;Facts Views Vis Obgyn,2011